Big PharmaiDRUGS
Live Big Pharmai price updates and the latest Big Pharmai news.
price
sponsored by
$0.00885
$0
(0%)
24h low
$0.007
24h high
$0.01
The live Big Pharmai price today is $0.009 with a 24-hour trading volume of $2.06M. The table above accurately updates our DRUGS price in real time. The price of DRUGS is down -1.24% since last hour, down -0.15% since yesterday. The live market cap, measured by multiplying the number of coins by the current price is $9.73M. DRUGS has a circulating supply of 1.10B coins and a max supply of 1.10B DRUGS.
Big Pharmai Stats
What is the market cap of Big Pharmai?
The current market cap of Big Pharmai is $10.12M. A high market capitalization implies that the asset is highly valued by the market.
What is the current trading activity of Big Pharmai?
Currently, 233.43M of DRUGS were traded within 24 hours of time. In other words, $2.06M have changed hands within the past 24 hours through trading. That's a change of -0.15%.
What is the current price of Big Pharmai?
The price of 1 Big Pharmai currently costs $0.009.
How many Big Pharmai are there?
The current circulating supply of Big Pharmai is 1.10B. This is the total amount of DRUGS that is available.
What is the relative popularity of Big Pharmai?
Big Pharmai (DRUGS) currently ranks 1724 among all known cryptocurrency assets. The popularity is based on relative market cap.
market data
$ 10.12M
-0.15 %
#1724
$ 2.06M
1,100,000,000
recent research
Research
Aave’s revenues have doubled from April lows and are fast approaching all-time highs. With 35% of borrow interest coming from ETH and 55% from stablecoins, Aave is emerging as a powerful proxy as an ETH and stablecoin beta. As looping strategies accelerate growth and Horizon positions the protocol to ride the RWA wave, Aave is shaping up as one of DeFi’s most compelling multi-narrative plays.
by Kunal Doshi
/
Research
Into 2026, we see a barbell as the most sensible way to express the thesis with Robinhood as the core, steadier compounder, and Coinbase as the higher-beta call option on the next crypto up-leg. Robinhood’s premium multiple is now earned by a broader, more durable revenue mix (options, NII, crypto) with identifiable execution catalysts (Bitstamp/WonderFi integration, continued Gold adoption, the banking rollout, and early tokenization/L2 efforts). Coinbase’s story skews more cyclical but gains structural heft from Deribit, Base economics, brand reputation, CaaS offerings, Custody, product expansions, and payment rails that can thicken Subscriptions & Services through a cycle.